Additionally, in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention, higher plasma MMP-2-levels at baseline were associated with increased myocardial infarct size and decreased left ventricular function after four months of follow-up [29]. Here, MMP2 is linked to myocardial infarction.